Biological quality of water intended for renal replacement therapy for patients admitted to the ICU during the SARS-CoV-2 virus pandemic

Ellen Gameiro Hilinski, Adriana Aparecida Buzzo Almodovar , Márcia Liane Buzzo — Tue, 27 May 2025 00:00:00 -0300

The number of patients admitted to Intensive Care Units (ICUs) with Acute Renal Failure (ARF) increased during the pandemic caused by SARS-CoV-2 virus worldwide, causing excessive overload in the hospital sector. This study evaluated the biological quality of water developed for dialysis treatment for patients admitted to ICUs, in relation to the parameters of heterotrophic bacteria, total coliforms and bacterial endotoxins. The analytical results obtained from the biological quality of treated water intended for patients admitted to ICUs with ARF undergoing replacement therapy treatment were compared, in the period before and after the pandemic. The components related to the tests for enumeration of heterotrophic bacteria, research of total coliforms and bacterial endotoxins in treated water samples, in accordance with the limitation criteria of the legislation, were between 90 to 97.7%, 97.1 to 100%, and 83.6 to 86.4%, respectively. This study helped to improve the effectiveness of technical teams' actions in defeating water that was damaged during dialysis therapy, providing a positive impact on the health of patients exposed to the treatment. In addition, the study aims to encourage many institutions to implement ongoing programs to adapt their water treatment systems.

EPIDEMIOLOGICAL ANALYSIS OF THE GROWTH IN THE USE OF SYNTHETIC CANNABINOIDS IN THE MUNICIPALITY OF SÃO PAULO

Thu, 20 Mar 2025 00:00:00 -0300

The use of synthetic cannabinoids, known as "zombie drug", “spice” or "K9," has significantly increased, especially in São Paulo, Brazil. These chemicals are much more potent than marijuana and have spread globally since the early 2000s. This study is a temporal ecological study with a literature review built upon the analysis of epidemiological bulletins from the municipality of São Paulo regarding the monitoring of synthetic cannabinoids. The results of this study indicated a significant increase in the number of notifications over the years from 2021 to 2024, mainly in 2023, with a trend of continued growth in 2024, albeit at a slower rate. The study also aimed to analyze the epidemiological profile of the user population, which was predominantly young brown-skinned men, primarily in the age range of 15 to 34 years. This research analyzed incidence rates throughout the years 2023 to 2024, also highlighting periods of peaks and declines. Finally, this study compared the trends observed in Brazil with those at the international level, emphasizing the growth of this drug in the market and its impact on public health.

BEPA. Boletim Epidemiológico Paulista

Biological quality of water intended for renal replacement therapy for patients admitted to the ICU during the SARS-CoV-2 virus pandemic

EPIDEMIOLOGICAL ANALYSIS OF THE GROWTH IN THE USE OF SYNTHETIC CANNABINOIDS IN THE MUNICIPALITY OF SÃO PAULO